These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
140 related items for PubMed ID: 2558771
1. Consistent reduction of ACTH responses to stimulation with CRH, vasopressin and hypoglycaemia in patients with major depression. Kathol RG, Jaeckle RS, Lopez JF, Meller WH. Br J Psychiatry; 1989 Oct; 155():468-78. PubMed ID: 2558771 [Abstract] [Full Text] [Related]
3. A comparison of the naloxone test with ovine CRH and insulin hypoglycaemia in the evaluation of the hypothalamic-pituitary-adrenal axis in normal man. Inder WJ, Ellis MJ, Evans MJ, Donald RA. Clin Endocrinol (Oxf); 1995 Oct; 43(4):425-31. PubMed ID: 7586616 [Abstract] [Full Text] [Related]
4. Effect of insulin-induced hypoglycaemia on secretion patterns and rates of corticotrophin-releasing hormone, arginine vasopressin and adrenocorticotrophin in horses. Alexander SL, Roud HK, Irvine CH. J Endocrinol; 1997 Jun; 153(3):401-9. PubMed ID: 9203994 [Abstract] [Full Text] [Related]
5. Hypothalamo-pituitary-adrenal cortical responses to low-dose physostigmine and arginine vasopressin administration: sex differences between major depressives and matched control subjects. Rubin RT, O'Toole SM, Rhodes ME, Sekula LK, Czambel RK. Psychiatry Res; 1999 Dec 13; 89(1):1-20. PubMed ID: 10643873 [Abstract] [Full Text] [Related]
9. Alprazolam attenuates vasopressin-stimulated adrenocorticotropin and cortisol release: evidence for synergy between vasopressin and corticotropin-releasing hormone in humans. Torpy DJ, Grice JE, Hockings GI, Walters MM, Crosbie GV, Jackson RV. J Clin Endocrinol Metab; 1994 Jul 13; 79(1):140-4. PubMed ID: 8027217 [Abstract] [Full Text] [Related]
10. Plasma corticotropin and cortisol responses to ovine corticotropin-releasing hormone (CRH), arginine vasopressin (AVP), CRH plus AVP, and CRH plus metyrapone in patients with Cushing's disease. Dickstein G, DeBold CR, Gaitan D, DeCherney GS, Jackson RV, Sheldon WR, Nicholson WE, Orth DN. J Clin Endocrinol Metab; 1996 Aug 13; 81(8):2934-41. PubMed ID: 8768855 [Abstract] [Full Text] [Related]
11. Adrenergic modulation of adrenocorticotropin responses to insulin-induced hypoglycemia and corticotropin-releasing hormone. Tomori N, Suda T, Nakagami Y, Tozawa F, Sumitomo T, Ushiyama T, Demura H, Shizume K. J Clin Endocrinol Metab; 1989 Jan 13; 68(1):87-93. PubMed ID: 2535853 [Abstract] [Full Text] [Related]
12. Responses induced by arginine-vasopressin injection in the plasma concentrations of adrenocorticotropic hormone, cortisol, growth hormone and metabolites around weaning time in goats. Katoh K, Yoshida M, Kobayashi Y, Onodera M, Kogusa K, Obara Y. J Endocrinol; 2005 Nov 13; 187(2):249-56. PubMed ID: 16293772 [Abstract] [Full Text] [Related]
13. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency. Fukata J, Usui T, Tsukada T, Nakai Y, Koh T, Ishihara T, Tanaka I, Uchida K, Yoshimasa T, Nakano R. J Clin Endocrinol Metab; 1990 Dec 13; 71(6):1624-31. PubMed ID: 2172283 [Abstract] [Full Text] [Related]
14. Endocrine responses to growth hormone-releasing hormone, thyrotropin-releasing hormone and corticotropin-releasing hormone in depression. Lesch KP, Müller U, Rupprecht R, Kruse K, Schulte HM. Acta Psychiatr Scand; 1989 Jun 13; 79(6):597-602. PubMed ID: 2548370 [Abstract] [Full Text] [Related]
15. Corticotropin releasing hormone: relevance to normal physiology and to the pathophysiology and differential diagnosis of hypercortisolism and adrenal insufficiency. Gold PW, Kling MA, Khan I, Calabrese JR, Kalogeras K, Post RM, Avgerinos PC, Loriaux DL, Chrousos GP. Adv Biochem Psychopharmacol; 1987 Jun 13; 43():183-200. PubMed ID: 3035886 [Abstract] [Full Text] [Related]
16. Corticotropin and cortisol response to human CRH as a probe for HPA system integrity in major depressive disorder. Lesch KP, Laux G, Schulte HM, Pfüller H, Beckmann H. Psychiatry Res; 1988 Apr 13; 24(1):25-34. PubMed ID: 2839859 [Abstract] [Full Text] [Related]
17. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy. Cleare AJ, Miell J, Heap E, Sookdeo S, Young L, Malhi GS, O'Keane V. J Clin Endocrinol Metab; 2001 Aug 13; 86(8):3545-54. PubMed ID: 11502777 [Abstract] [Full Text] [Related]
18. Hexarelin, a synthetic growth-hormone releasing peptide, shows no interaction with corticotropin-releasing hormone and vasopressin on adrenocorticotropin and cortisol secretion in humans. Arvat E, Maccagno B, Ramunni J, Di Vito L, Broglio F, Deghenghi R, Camanni F, Ghigo E. Neuroendocrinology; 1997 Dec 13; 66(6):432-8. PubMed ID: 9430449 [Abstract] [Full Text] [Related]
19. The acute effect of lowering plasma cortisol on the secretion of corticotropin-releasing hormone, arginine vasopressin, and adrenocorticotropin as revealed by intensive sampling of pituitary venous blood in the normal horse. Alexander SL, Irvine CH, Livesey JH, Donald RA. Endocrinology; 1993 Aug 13; 133(2):860-6. PubMed ID: 8393777 [Abstract] [Full Text] [Related]
20. An investigation of hypothalamic-pituitary-adrenal axis hyperactivity in anorexia nervosa: the role of CRH and AVP. Connan F, Lightman SL, Landau S, Wheeler M, Treasure J, Campbell IC. J Psychiatr Res; 2007 Aug 13; 41(1-2):131-43. PubMed ID: 16455105 [Abstract] [Full Text] [Related] Page: [Next] [New Search]